Ortiza, Charydel .
HRN: 21-51-43 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2022
CO-AMOXICLAV 625MG (TAB)
06/27/2022
07/04/2022
PO
625
BId
Lacerated Wound
Waiting Final Action
06/30/2022
CEFTRIAXONE 1G (VIAL)
06/30/2022
07/06/2022
IV
2g
Q24
Burn Wounds
Waiting Final Action
07/03/2022
MUPIROCIN 2%, 15G (TUBE)
07/03/2022
07/10/2022
ID
2%
BID
Wound Infection
Waiting Final Action